First monkeypox case reported in Sonoma Valley
A monkeypox case has been identified at Sonoma Valley Community Health Center, one of a handful of cases reported in Sonoma County. Meanwhile, the illness is moving rapidly across the state, nation and world, prompting conflicting opinions among medical experts as many call for a more proactive approach to curbing the spread.
Monkeypox was first detected in humans in 1970 and there have been occasional outbreaks, but the current outbreak is by far the largest, with 16,358 cases in more than 60 countries, including 2,891 in the United States and 434 in California as of July 23, according to the Centers of Disease Control and Prevention (CDC). There have been few hospitalizations and deaths associated with the disease.
Privacy laws restrict health-care providers from releasing an individual’s personal medical information, but some details about three confirmed or probable cases in Sonoma County have come to light. They are all men who displayed flu-like symptoms, including muscle aches, a headache, a rash and a subjective fever, which is a fever that someone feels, as opposed to something objectively measured by a thermometer. The people are in different stages of the illness and none have required hospitalization.
One man contracted monkeypox after traveling internationally and another did so after traveling to another state. One of the people contracted it after being exposed to another local cases. Public health officials are investigating eight close contacts to these men, but there is no evidence that others have contracted the virus.
Sebastopol resident Mitcho Thompson told NBC Bay Area that after testing positive for COVID at the end of June, he started seeing red lesions on his back, legs, arms and neck, a telltale symptom of monkeypox. He said that his doctor told him that he also contracted monkeypox, noting that it’s rare but possible to have both viruses simultaneously.
Dr. John Swartzberg, clinical professor emeritus of infectious diseases and immunology at the University of California, Berkeley, emphasized that monkeypox has no relationship to the coronavirus and it’s far less transmissible. Dr. Monica Gandhi, professor of clinical medicine at University of California, San Francisco (UCSF), said she doesn’t believe monkeypox is related to COVID in any way, except for one possibility.
“We may be more vulnerable to other infections after staying away from infections for the past two years of COVID restrictions due to an ‘immune deficit’ from not being exposed to other pathogens [viruses],” she said.
Sonoma Valley Community Health Center (SVCHC) received monkeypox vaccines from the state and administered doses to two people who have been in contact with the infected Sonoma Valley resident. The health center is collaborating with Sonoma County’s Public Health Division to learn how to address additional cases if they turn up.
“The county has taken a proactive stance in ensuring that we have a small number of vaccine doses to be administered when public health so directs,” said Cheryl Johnson, CEO of the health center.
No monkeypox cases have been diagnosed at Sonoma Valley Hospital (SVH), which is working closely with the infectious disease team at UCSF and the California Department of Public Health to make sure that it follows the best practices and protocols.
Vaccine distribution issues
“Allocations of the monkeypox vaccines are determined by the California Department of Public Health, from whom we will receive guidance for staff and patient safety and care,” said Kylie Cooper, director of quality and risk for the hospital.
The Jynneous vaccine, which is also used to prevent smallpox, has been licensed by the U.S. Food and Drug Administration to prevent monkeypox infection, but it has never been widely used in response to an outbreak. A very limited supply of it was available in the US at the beginning of the outbreak, but since late May, more than 300,000 doses have been made available nationally.
Following recent complaints about the federal government's slow response to the outbreak, the U.S. Department of Health and Human Services (HHS) announced on July 15 that it ordered another 2.5 million doses of the vaccine from Bavarian Nordic in Copenhagen. Deliveries are expected to arrive at the Strategic National Stockpile later this year and continue through early 2023.
“There is no need for alarm, but there is need for a robust public health and medical response to stop the spread,” Swartzberg said. “We have the tools to do this, with the vaccine.”
Yet on Saturday, Tedros Adhanom Ghebreyesus, director general of the World Health Organization, declared that monkeypox is an “extraordinary” situation that qualifies as a global emergency. The United Nations’ emergency committee was divided on whether to declare it as an emergency, with Ghebreyesus acting as a tiebreaker.
UPDATED: Please read and follow our commenting policy: